Copyright
©2014 Baishideng Publishing Group Co.
World J Respirol. Mar 28, 2014; 4(1): 1-7
Published online Mar 28, 2014. doi: 10.5320/wjr.v4.i1.1
Published online Mar 28, 2014. doi: 10.5320/wjr.v4.i1.1
Characteristic | n = 61 |
Gender | |
Male | 43 |
Female | 18 |
Age, yr | 66 (42-79) |
Histology | |
Adenocarcinoma | 45 |
Squamous cell carcinoma | 13 |
Pleomorphic carcinoma | 2 |
Giant cell carcinoma | 1 |
Lesion site | |
Right | 42 |
Left | 19 |
Lesion location | |
Upper | 38 |
Middle | 1 |
Lower | 22 |
Pathological stage (7th) | |
IB | 17 |
IIA | 14 |
IIB | 8 |
IIIA | 22 |
Surgical procedure | |
Sublobar resection | 2 |
Lobectomy | 58 |
Pneumonectomy | 1 |
- Citation: Uramoto H, Nakanishi R, Uchiyama A, Inoue M, Sugaya M, Iwata T, Ebi N, Hanagiri T, Tanaka F. Phase II trial of carboplatin/docetaxel in patients with resected NSCLC. World J Respirol 2014; 4(1): 1-7
- URL: https://www.wjgnet.com/2218-6255/full/v4/i1/1.htm
- DOI: https://dx.doi.org/10.5320/wjr.v4.i1.1